• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[埃罗省肿瘤泌尿专科登记处(RHESOU):法国首个肿瘤泌尿专科登记处。一年经验]

[RHESOU (Registry in HErault Specialized in Onco-Urology) : the first French Registry specialized in Onco-Urology. One-year experience].

作者信息

Trouche-Sabatier S G, Rebillard X, Iborra F, Azria D, Daures J-P, Poinas G, Abdo N, Delbos O, Gevorgyan A, Marchal S, Guillon R, Millet I, Lamy P-J, Lauche O, Reis-Borges R, Serre I, Topart D, Tretarre B

机构信息

Registre des tumeurs de l'Hérault, Montpellier, France.

Comité de pilotage, Montpellier, France; Clinique Beau Soleil, Montpellier, France.

出版信息

Prog Urol. 2020 Dec;30(16):1038-1044. doi: 10.1016/j.purol.2020.09.015. Epub 2020 Oct 1.

DOI:10.1016/j.purol.2020.09.015
PMID:33012630
Abstract

PURPOSE

In 2016, the Herault tumor registry collected 1961cancers in urology (21.4 % from all Herault cancers this year). RHESOU was created to complete RTH' data with specific parameters in onco-urology. The aim of this study is to describe RHESOU and to give some examples with our first results.

MATERIAL AND METHODS

In November 2018, RHESOU (Registry HErault Specialised in Onco-Urology) was founded with the same registry recommendations. It collects specific oncologic parameters and also complete RTH's data. For each urological cancer, a specific survey with different choices was performed to collect a maximum of data which could be present in patients' file. These surveys were used for urological cancers cases that live in Herault in 2017.

RESULTS

In 2017, we collected 970 prostate cancers, 581 bladder cancers, 212 kidney cancers, 51 upper excretory tract cancers, 28 testicle cancers and 9 penil cancers. Our urological data collection gives many possibilities to create many requests for detailed analysis in urological cancers. In this article, we reported data from kidney, bladder and prostate cancers.

CONCLUSIONS

RHESOU is a new tool opened to the different urologic corporations (urologists, pathologists, oncologists, radiotherapists, radiologists) that permits an overview in urological cancers in Herault. Finally, one important aim is that this tool will be adapted when new treatments or new important parameters appear in the years ahead.

LEVEL OF EVIDENCE

摘要

目的

2016年,埃罗省肿瘤登记处收集了1961例泌尿外科癌症病例(占该年埃罗省所有癌症病例的21.4%)。创建RHESOU是为了用肿瘤泌尿学的特定参数完善RTH的数据。本研究的目的是描述RHESOU并给出一些初步结果示例。

材料与方法

2018年11月,RHESOU(埃罗省肿瘤泌尿学专科登记处)依据相同的登记建议成立。它收集特定的肿瘤学参数并完善RTH的数据。对于每例泌尿外科癌症,进行了一项有不同选项的特定调查,以收集患者病历中可能存在的最多数据。这些调查用于2017年居住在埃罗省的泌尿外科癌症病例。

结果

2017年,我们收集了970例前列腺癌、581例膀胱癌、212例肾癌、51例上尿路癌、28例睾丸癌和9例阴茎癌。我们的泌尿外科数据收集为开展许多泌尿外科癌症详细分析的请求提供了诸多可能性。在本文中,我们报告了肾癌、膀胱癌和前列腺癌的数据。

结论

RHESOU是一个面向不同泌尿外科机构(泌尿外科医生、病理学家、肿瘤学家、放射治疗师、放射科医生)开放的新工具,可对埃罗省的泌尿外科癌症进行全面了解。最后,一个重要目标是在未来几年出现新治疗方法或新的重要参数时,该工具将进行调整。

证据级别

3级。

相似文献

1
[RHESOU (Registry in HErault Specialized in Onco-Urology) : the first French Registry specialized in Onco-Urology. One-year experience].[埃罗省肿瘤泌尿专科登记处(RHESOU):法国首个肿瘤泌尿专科登记处。一年经验]
Prog Urol. 2020 Dec;30(16):1038-1044. doi: 10.1016/j.purol.2020.09.015. Epub 2020 Oct 1.
2
[Bladder tumors in the Hérault department: Results of the Hérault tumor registry registration from1987 to 2019].
Prog Urol. 2023 Dec;33(15-16):974-982. doi: 10.1016/j.purol.2023.08.015. Epub 2023 Aug 28.
3
[Adhesion of urologists to the recommendations of the French Urological Association Cancer Committee (CCAFU) in the imaging work-up of localized prostate cancer].
Prog Urol. 2022 Dec;32(16):1446-1454. doi: 10.1016/j.purol.2022.09.021. Epub 2022 Nov 4.
4
[Renal cell carcinoma in the department of Hérault: Results over a 30 year period].[埃罗省(法国南部一省)的肾细胞癌:30年期间的结果]
Prog Urol. 2021 Mar;31(3):175-182. doi: 10.1016/j.purol.2020.10.001. Epub 2020 Nov 5.
5
[Urologic cancer at the Hérault department: 14 years of continuous registration].[埃罗省的泌尿系统癌症:连续14年的登记情况]
Prog Urol. 2003 Jun;13(3):394-403.
6
[Cancers of the external genital organs of male in Hérault: Results from the Hérault tumor register (RTH) over a period of 30 years (1987-2016)].埃罗省男性外生殖器癌症:埃罗省肿瘤登记处(RTH)30年(1987 - 2016年)的结果
Prog Urol. 2021 Apr;31(5):282-292. doi: 10.1016/j.purol.2020.08.054. Epub 2021 Feb 13.
7
Impact of automated data collection from urology offices: improving incidence and treatment reporting in urologic cancers.泌尿外科办公室自动数据收集的影响:改善泌尿系统癌症的发病率和治疗报告
J Registry Manag. 2010 Winter;37(4):141-7.
8
[The French clinical trials ongoing (GETUG and AFU) on urothelial carcinomas, kidney and prostate cancers].[法国正在进行的关于尿路上皮癌、肾癌和前列腺癌的临床试验(GETUG和AFU)]
Prog Urol. 2010 Mar;20 Suppl 1:S84-9. doi: 10.1016/S1166-7087(10)70035-X.
9
[Update urooncology: news with clinical relevance from major scientific meetings 2012].[2012年泌尿肿瘤学最新进展:来自主要科学会议的具有临床相关性的消息]
Aktuelle Urol. 2012 Dec;43(6):376-87. doi: 10.1055/s-0032-1332786. Epub 2012 Dec 19.
10
[News with clinical relevance from major scientific meetings 2014 - Update Urooncology].
Aktuelle Urol. 2015 Mar;46(2):106-17. doi: 10.1055/s-0035-1549871. Epub 2015 Apr 24.